UK Markets closed

Clinigen Group Plc (CLIN.L)

LSE - LSE Delayed price. Currency in GBp
Add to watchlist
925.00+1.00 (+0.11%)
At close: 05:15PM BST
Currency in GBp

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 1.47
52-week change 3N/A
S&P500 52-week change 3N/A
52-week high 3948.05
52-week low 39.25
50-day moving average 3899.45
200-day moving average 3745.26

Share statistics

Avg vol (3-month) 31.68M
Avg vol (10-day) 31.15M
Shares outstanding 5133.37M
Implied shares outstanding 6N/A
Float 8110.77M
% held by insiders 111.83%
% held by institutions 170.89%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 40.08
Forward annual dividend yield 40.82%
Trailing annual dividend rate 30.08
Trailing annual dividend yield 30.01%
5-year average dividend yield 40.75
Payout ratio 426.06%
Dividend date 3N/A
Ex-dividend date 402 Dec 2021
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in GBP.

Fiscal year

Fiscal year ends 30 Jun 2021
Most-recent quarter (mrq)30 Jun 2021

Profitability

Profit margin 5.79%
Operating margin (ttm)11.19%

Management effectiveness

Return on assets (ttm)3.32%
Return on equity (ttm)8.90%

Income statement

Revenue (ttm)523.6M
Revenue per share (ttm)3.94
Quarterly revenue growth (yoy)19.10%
Gross profit (ttm)198M
EBITDA 107.9M
Net income avi to common (ttm)39.7M
Diluted EPS (ttm)22.30
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)82.9M
Total cash per share (mrq)0.62
Total debt (mrq)418.7M
Total debt/equity (mrq)93.67
Current ratio (mrq)1.75
Book value per share (mrq)3.36

Cash flow statement

Operating cash flow (ttm)45.2M
Levered free cash flow (ttm)-17.45M